Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endologix Inc (NASDAQ:ELGX)

7.07
Delayed Data
As of 3:59pm ET
 -0.015 / -0.21%
Today’s Change
4.78
Today|||52-Week Range
14.50
+23.51%
Year-to-Date
Endologix Poised for a Potentially Volatile Breakout
Mar 28 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close7.08
Today’s open7.08
Day’s range6.99 - 7.19
Volume814,017
Average volume (3 months)2,127,018
Market cap$587.1M
Dividend yield--
Data as of 3:59pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)-154.67%
Earnings growth (this year)+21.16%
Earnings growth (next 5 years)+95.60%
Revenue growth (last year)+25.59%
P/E ratioNM
Price/Sales2.40
Price/Book5.20

Competitors

 Today’s
change
Today’s
% change
GNMKGenMark Diagnostics ...+0.11+0.88%
ANIKAnika Therapeutics I...-0.28-0.66%
ATRCAtriCure Inc+0.09+0.48%
ANGOAngioDynamics Inc+0.24+1.41%
Data as of 3:59pm ET, 03/29/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$192.9M
Annual profit (last year)-$154.7M
Net profit margin-80.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
John D. McDermott
President
Robert D. Mitchell
Corporate headquarters
Irvine, California

Forecasts


Search for Jobs